BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹31 Cr | ₹20 Cr | ₹23 Cr | ₹-1.54 Cr | ₹27 Cr |
What is the latest Cash Flow from Operating Activities ratio of BAL PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹31 Cr |
| Mar2025 | ₹20 Cr |
| Mar2024 | ₹23 Cr |
| Mar2023 | ₹-1.54 Cr |
| Mar2022 | ₹27 Cr |
How is Cash Flow from Operating Activities of BAL PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹31 Cr | 51.78 | |
| Mar2025 | ₹20 Cr | -10.92 | |
| Mar2024 | ₹23 Cr | Positive | |
| Mar2023 | ₹-1.54 Cr | Negative | |
| Mar2022 | ₹27 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹169.1 Cr | 20.1% | 19.2% | 27.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 20.1% |
19.2% |
27.8% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses